RNF213 and adenocarcinoma: Among the most-mutated genes, KRAS and TP53 were mutated only in cancers, while five other genes (HNF1A, CREBBP, RNF213, CASC5, and APC) were mutated with similar frequencies in adenocarcinomas and neuroendocrine tumors.